 | • レポートコード：B-GIR08C4111 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、オラパリブの世界市場について調べ、まとめました。種類別セグメントは、錠剤、カプセル等、用途別セグメントは、卵巣がん、乳がん、前立腺がん、その他等に区分しました。オラパリブの世界市場概観、企業動向、企業別オラパリブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・オラパリブの市場概観 ・オラパリブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・オラパリブの企業別販売動向、市場シェア、市場集中度、競争動向 ・オラパリブの世界市場規模 ・オラパリブの北米市場分析（アメリカ、カナダ、メキシコ等） ・オラパリブのアメリカ市場規模推移 ・オラパリブのカナダ市場規模推移 ・オラパリブのメキシコ市場規模推移 ・オラパリブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・オラパリブのドイツ市場規模推移 ・オラパリブのイギリス市場規模推移 ・オラパリブのロシア市場規模推移 ・オラパリブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・オラパリブの日本市場規模推移 ・オラパリブの中国市場規模推移 ・オラパリブの韓国市場規模推移 ・オラパリブのインド市場規模推移 ・オラパリブの東南アジア市場規模推移 ・オラパリブの南米市場分析（ブラジル、アルゼンチン等） ・オラパリブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・オラパリブの種類別分析/販売量、売上、市場シェア（錠剤、カプセル） ・オラパリブの用途別分析/市場規模（卵巣がん、乳がん、前立腺がん、その他） ・オラパリブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・オラパリブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Olaparib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Olaparib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AstraZeneca
Everest Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablets
Capsules
Market Segment by Applications, can be divided into
Ovarian Cancers
Breast Cancers
Prostate Cancers
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Olaparib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Olaparib, with price, sales, revenue and global market share of Olaparib in 2017 and 2018.
Chapter 3, the Olaparib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Olaparib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Olaparib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Olaparib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Olaparib Introduction
1.2 Market Analysis by Type
1.2.1 Tablets
1.2.2 Capsules
1.3 Market Analysis by Applications
1.3.1 Ovarian Cancers
1.3.2 Breast Cancers
1.3.3 Prostate Cancers
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Olaparib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Olaparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Everest Pharmaceuticals
2.2.1 Business Overview
2.2.2 Olaparib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Everest Pharmaceuticals Olaparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Olaparib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Olaparib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Olaparib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Olaparib Manufacturer Market Share in 2018
3.3.2 Top 6 Olaparib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Olaparib Market Analysis by Regions
4.1 Global Olaparib Sales, Revenue and Market Share by Regions
4.1.1 Global Olaparib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Olaparib Revenue and Market Share by Regions (2014-2019)
4.2 North America Olaparib Sales and Growth Rate (2014-2019)
4.3 Europe Olaparib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Olaparib Sales and Growth Rate (2014-2019)
4.5 South America Olaparib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Olaparib Sales and Growth Rate (2014-2019)
5 North America Olaparib by Country
5.1 North America Olaparib Sales, Revenue and Market Share by Country
5.1.1 North America Olaparib Sales and Market Share by Country (2014-2019)
5.1.2 North America Olaparib Revenue and Market Share by Country (2014-2019)
5.2 United States Olaparib Sales and Growth Rate (2014-2019)
5.3 Canada Olaparib Sales and Growth Rate (2014-2019)
5.4 Mexico Olaparib Sales and Growth Rate (2014-2019)
6 Europe Olaparib by Country
6.1 Europe Olaparib Sales, Revenue and Market Share by Country
6.1.1 Europe Olaparib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Olaparib Revenue and Market Share by Country (2014-2019)
6.2 Germany Olaparib Sales and Growth Rate (2014-2019)
6.3 UK Olaparib Sales and Growth Rate (2014-2019)
6.4 France Olaparib Sales and Growth Rate (2014-2019)
6.5 Russia Olaparib Sales and Growth Rate (2014-2019)
6.6 Italy Olaparib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Olaparib by Country
7.1 Asia-Pacific Olaparib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Olaparib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Olaparib Revenue and Market Share by Country (2014-2019)
7.2 China Olaparib Sales and Growth Rate (2014-2019)
7.3 Japan Olaparib Sales and Growth Rate (2014-2019)
7.4 Korea Olaparib Sales and Growth Rate (2014-2019)
7.5 India Olaparib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Olaparib Sales and Growth Rate (2014-2019)
8 South America Olaparib by Country
8.1 South America Olaparib Sales, Revenue and Market Share by Country
8.1.1 South America Olaparib Sales and Market Share by Country (2014-2019)
8.1.2 South America Olaparib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Olaparib Sales and Growth Rate (2014-2019)
8.3 Argentina Olaparib Sales and Growth Rate (2014-2019)
8.4 Colombia Olaparib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Olaparib by Countries
9.1 Middle East and Africa Olaparib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Olaparib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Olaparib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Olaparib Sales and Growth Rate (2014-2019)
9.3 Turkey Olaparib Sales and Growth Rate (2014-2019)
9.4 Egypt Olaparib Sales and Growth Rate (2014-2019)
9.5 Nigeria Olaparib Sales and Growth Rate (2014-2019)
9.6 South Africa Olaparib Sales and Growth Rate (2014-2019)
10 Global Olaparib Market Segment by Type
10.1 Global Olaparib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Olaparib Sales and Market Share by Type (2014-2019)
10.1.2 Global Olaparib Revenue and Market Share by Type (2014-2019)
10.2 Tablets Sales Growth and Price
10.2.1 Global Tablets Sales Growth (2014-2019)
10.2.2 Global Tablets Price (2014-2019)
10.3 Capsules Sales Growth and Price
10.3.1 Global Capsules Sales Growth (2014-2019)
10.3.2 Global Capsules Price (2014-2019)
11 Global Olaparib Market Segment by Application
11.1 Global Olaparib Sales Market Share by Application (2014-2019)
11.2 Ovarian Cancers Sales Growth (2014-2019)
11.3 Breast Cancers Sales Growth (2014-2019)
11.4 Prostate Cancers Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Olaparib Market Forecast (2019-2024)
12.1 Global Olaparib Sales, Revenue and Growth Rate (2019-2024)
12.2 Olaparib Market Forecast by Regions (2019-2024)
12.2.1 North America Olaparib Market Forecast (2019-2024)
12.2.2 Europe Olaparib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Olaparib Market Forecast (2019-2024)
12.2.4 South America Olaparib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Olaparib Market Forecast (2019-2024)
12.3 Olaparib Market Forecast by Type (2019-2024)
12.3.1 Global Olaparib Sales Forecast by Type (2019-2024)
12.3.2 Global Olaparib Market Share Forecast by Type (2019-2024)
12.4 Olaparib Market Forecast by Application (2019-2024)
12.4.1 Global Olaparib Sales Forecast by Application (2019-2024)
12.4.2 Global Olaparib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Olaparib Picture
Table Product Specifications of Olaparib
Figure Global Sales Market Share of Olaparib by Types in 2018
Table Olaparib Types for Major Manufacturers
Figure Tablets Picture
Figure Capsules Picture
Figure Olaparib Sales Market Share by Applications in 2018
Figure Ovarian Cancers Picture
Figure Breast Cancers Picture
Figure Prostate Cancers Picture
Figure Other Picture
Figure United States Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure France Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure China Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure India Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Olaparib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Olaparib Revenue (Value) and Growth Rate (2014-2024)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Olaparib Type and Applications
Table AstraZeneca Olaparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Everest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Everest Pharmaceuticals Olaparib Type and Applications
Table Everest Pharmaceuticals Olaparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Olaparib Sales by Manufacturer (2017-2018)
Figure Global Olaparib Sales Market Share by Manufacturer in 2017
Figure Global Olaparib Sales Market Share by Manufacturer in 2018
Table Global Olaparib Revenue by Manufacturer (2017-2018)
Figure Global Olaparib Revenue Market Share by Manufacturer in 2017
Figure Global Olaparib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Olaparib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Olaparib Manufacturer (Revenue) Market Share in 2018
Figure Global Olaparib Sales and Growth Rate (2014-2019)
Figure Global Olaparib Revenue and Growth Rate (2014-2019)
Table Global Olaparib Sales by Regions (2014-2019)
Table Global Olaparib Sales Market Share by Regions (2014-2019)
Table Global Olaparib Revenue by Regions (2014-2019)
Figure Global Olaparib Revenue Market Share by Regions (2014-2019)
Figure Global Olaparib Revenue Market Share by Regions in 2018
Figure North America Olaparib Sales and Growth Rate (2014-2019)
Figure Europe Olaparib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Olaparib Sales and Growth Rate (2014-2019)
Figure South America Olaparib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Olaparib Sales and Growth Rate (2014-2019)
Figure North America Olaparib Revenue and Growth Rate (2014-2019)
Table North America Olaparib Sales by Countries (2014-2019)
Table North America Olaparib Sales Market Share by Countries (2014-2019)
Figure North America Olaparib Sales Market Share by Countries (2014-2019)
Figure North America Olaparib Sales Market Share by Countries in 2018
Table North America Olaparib Revenue by Countries (2014-2019)
Table North America Olaparib Revenue Market Share by Countries (2014-2019)
Figure North America Olaparib Revenue Market Share by Countries (2014-2019)
Figure North America Olaparib Revenue Market Share by Countries in 2018
Figure United States Olaparib Sales and Growth Rate (2014-2019)
Figure Canada Olaparib Sales and Growth Rate (2014-2019)
Figure Mexico Olaparib Sales and Growth Rate (2014-2019)
Figure Europe Olaparib Revenue and Growth Rate (2014-2019)
Table Europe Olaparib Sales by Countries (2014-2019)
Table Europe Olaparib Sales Market Share by Countries (2014-2019)
Table Europe Olaparib Revenue by Countries (2014-2019)
Figure Europe Olaparib Revenue Market Share by Countries (2014-2019)
Figure Europe Olaparib Revenue Market Share by Countries in 2018
Figure Germany Olaparib Sales and Growth Rate (2014-2019)
Figure UK Olaparib Sales and Growth Rate (2014-2019)
Figure France Olaparib Sales and Growth Rate (2014-2019)
Figure Russia Olaparib Sales and Growth Rate (2014-2019)
Figure Italy Olaparib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Olaparib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Olaparib Sales by Countries (2014-2019)
Table Asia-Pacific Olaparib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Olaparib Sales Market Share by Countries 2018
Table Asia-Pacific Olaparib Revenue by Countries (2014-2019)
Figure Asia-Pacific Olaparib Revenue Market Share by Countries 2018
Figure China Olaparib Sales and Growth Rate (2014-2019)
Figure Japan Olaparib Sales and Growth Rate (2014-2019)
Figure Korea Olaparib Sales and Growth Rate (2014-2019)
Figure India Olaparib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Olaparib Sales and Growth Rate (2014-2019)
Figure South America Olaparib Revenue and Growth Rate (2014-2019)
Table South America Olaparib Sales by Countries (2014-2019)
Table South America Olaparib Sales Market Share by Countries (2014-2019)
Figure South America Olaparib Sales Market Share by Countries in 2018
Table South America Olaparib Revenue by Countries (2014-2019)
Table South America Olaparib Revenue Market Share by Countries (2014-2019)
Figure South America Olaparib Revenue Market Share by Countries in 2018
Figure Brazil Olaparib Sales and Growth Rate (2014-2019)
Figure Argentina Olaparib Sales and Growth Rate (2014-2019)
Figure Colombia Olaparib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Olaparib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Olaparib Sales by Countries (2014-2019)
Table Middle East and Africa Olaparib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Olaparib Sales Market Share by Countries in 2018
Table Middle East and Africa Olaparib Revenue by Countries (2014-2019)
Table Middle East and Africa Olaparib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Olaparib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Olaparib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Olaparib Sales and Growth Rate (2014-2019)
Figure UAE Olaparib Sales and Growth Rate (2014-2019)
Figure Egypt Olaparib Sales and Growth Rate (2014-2019)
Figure Nigeria Olaparib Sales and Growth Rate (2014-2019)
Figure South Africa Olaparib Sales and Growth Rate (2014-2019)
Table Global Olaparib Sales by Type (2014-2019)
Table Global Olaparib Sales Share by Type (2014-2019)
Table Global Olaparib Revenue by Type (2014-2019)
Table Global Olaparib Revenue Share by Type (2014-2019)
Figure Global Tablets Sales Growth (2014-2019)
Figure Global Tablets Price (2014-2019)
Figure Global Capsules Sales Growth (2014-2019)
Figure Global Capsules Price (2014-2019)
Table Global Olaparib Sales by Application (2014-2019)
Table Global Olaparib Sales Share by Application (2014-2019)
Figure Global Breast Cancers Sales Growth (2014-2019)
Figure Global Prostate Cancers Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Olaparib Sales, Revenue and Growth Rate (2019-2024)
Table Global Olaparib Sales Forecast by Regions (2019-2024)
Table Global Olaparib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Olaparib Market Forecast (2019-2024)
Figure Europe Sales Olaparib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Olaparib Market Forecast (2019-2024)
Figure South America Sales Olaparib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Olaparib Market Forecast (2019-2024)
Table Global Olaparib Sales Forecast by Type (2019-2024)
Table Global Olaparib Market Share Forecast by Type (2019-2024)
Table Global Olaparib Sales Forecast by Application (2019-2024)
Table Global Olaparib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
小分子標的癌療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Small Molecule Targeted Cancer Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chi…- 癌バイオ医薬品の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Cancer is a complex invasive genetic disease that causes significant mortality rate worldwide. C…
- 乳がんPARP阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global PARP Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially i…
- 世界の錠剤およびカプセル包装市場2019 The global Tablets and Capsules Packaging market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Tablets and Capsules Packaging market status and forecast, categorizes the global Tablets and Capsul…
- 世界の細胞診市場：市場規模・現状・予測 In 2018, the global Cytology Examination market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Cytology Examination status, future forecast, growth opportunity, key market and key players. The study …